Day: January 5, 2021

FRAMINGHAM, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the H.C. Wainwright BioConnect Conference, which will be held January 11-14, 2021.Chief Executive Officer, Terrence W. Norchi, MD, and Chief Financial Officer, Richard Davis, are scheduled to present via webcast, which will be available on-demand as of 6:00 AM ET, Monday, Jan. 11, 2021. You may access the live webcast here: https://journey.ct.events/view/69fcfc59-7ff6-41b6-bbe7-17285bda3d86.Conference attendees may request meetings with management here: https://hcwevents.com/bioconnect/.After the event, the presentation will be available here: https://ir.archtherapeutics.com/presentations.About...

VANCOUVER, British Columbia, Jan. 05, 2021 (GLOBE NEWSWIRE) — Marathon Patent Group Inc. (NASDAQ: MARA), (“Marathon”) and DMG Blockchain Solutions Inc. (TSX-V: DMGI) (DMGGF: OTC US) (FRANKFURT: 6AX) (“DMG”) have entered into a non-binding memorandum of understanding to form Digital Currency Miners of North America (“DCMNA”), which will be a U.S.-based non-profit entity whose mission is to create a better mining environment for North American miners, to help improve their financial performance, and to create North America’s first cooperative mining pool.Marathon Patent Group and DMG’s U.S. subsidiary, Blockseer, are working together to establish DCMNA, a non-profit entity focused on North American digital currency opportunities, including decentralizing the Bitcoin hashrate and providing more transparency for North American miners....

BOWIE, Md., Jan. 05, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Jonathan R. Boldt, chief financial officer of Inovalon, will present at the 39th Annual J.P. Morgan Healthcare Conference, which will be held virtually.The virtual presentation will take place at 10:00 a.m. (EST) on Tuesday, January 12, 2021. Investors may access a live audio webcast of the presentation on the Investor Relations section of Inovalon’s website at www.inovalon.com. An archived version will remain posted for a limited time.About InovalonInovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform,...

LEXINGTON, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc., (Nasdaq: KLDO) today announced that Dan Menichella, Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference at 2:00 p.m. EST on Thursday, Jan. 14, 2021.A live audio webcast of the presentation and question and answer session can be accessed on the Investors & Media section of the Kaleido website at https://investors.kaleido.com/events-presentations. An archived replay will be accessible following the event.About Kaleido BiosciencesKaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development...

MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in a fireside chat at the ICR Conference 2021, which is being held virtually from January 11th-14th. The fireside chat will be held on Thursday, January 14th at 8:30 a.m. Eastern Time.A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company’s investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.About Tactile MedicalTactile Medical is a leader in developing and marketing at-home therapy devices that...

Exclusive distribution agreement for initial term of three yearsAnnar commits to minimum purchase of 10 Unyvero systems during initial term   Annar to seek regulatory clearance for Unyvero products in ColombiaGAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Jan. 05, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that its subsidiary Curetis GmbH has entered into a distribution agreement with Annar Health Technologies (“Annar”) for Colombia. Annar, headquartered in Bogotá, is Colombia’s leading diagnostics distributor that is already working with numerous renowned global IVD manufacturers.Under the distribution agreement, Annar has the exclusive rights to commercialize the Curetis...

SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 39th Annual Healthcare Conference, held virtually January 11-14, 2021.ICU Medical’s presentation will be on Wednesday, January 13, 2021 at 8:40 a.m. PST (11:40 a.m. EST).  The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.About ICU Medical, Inc.ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy,...

SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced its participation in the 2021 ICR Conference. Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder of Progenity, will present a company overview on Thursday, January 14, 2021 at 4 p.m. ET (1 p.m. PT).A live audio webcast of the presentation will be available in the Investors section of the company’s website at progenity.com/presentations, with an archived replay available following the event.About ProgenityProgenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision...